Global Cough Assist Devices Market, By Product (Automatic Cough Assist Device, Manual Cough Assist Device), Choice of Delivery (Face Mask, Mouth Piece, Adapter), End User (Hospitals, Home Care Settings, Other End Users) – Industry Trends and Forecast to 2030.
Cough Assist Devices Market Analysis and Size
The significant increase in the number of patients suffering from chronic breathing disorders, combined with rapid technological advancements in medical devices, is expected to drive the growth of the cough assist devices market. Asthma affects more than 25 million people in the United States today. COPD has been diagnosed in approximately 14.8 million adults, with an additional 12 million people undiagnosed. Product advancement activities by major players and the introduction of innovative solutions are factors that are expected to have an impact on the growth of the market.
Data Bridge Market Research analyses that the cough assist devices market which was USD 212.58 million in 2022, is expected to reach USD 423.59 million by 2030, at a CAGR of 9.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cough Assist Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Automatic Cough Assist Device, Manual Cough Assist Device), Choice of Delivery (Face Mask, Mouth Piece, Adapter), End User (Hospitals, Home Care Settings, Other End Users)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Percussionaire Corp. (U.S.), Ventec Life Systems (U.S.), Air Liquide Medical Systems (India), Viemed (U.S.), West Care Medical (Canada), McKesson Medical-Surgical (U.S.), Aetna Inc. (U.S.), Dymedso (U.S.), PARI GmbH (Germany), Monaghan (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cough assist devices are useful in respiratory care and in cases of critical illness. This device is a proactive requirement for all types of spinal muscular atrophy patients. The device facilitates cough secretion from the lungs by causing a quick reverse in flow directions.
Cough Assist Devices Market Dynamics
Drivers
- Rising injuries in the spinal cord
Injuries to the spinal cord in the mid-cervical vertebrae (C3, C4, and C5) affect the respiratory muscles, which may increase product demand. For instance, according to Australian Government statistics published in 2021, the age-standardized incidence rate of persistent traumatic SCI was 8.6 cases per million population aged 15 and over in Australia between 2017 and 2018. Aspire, a leading national charity that supports spinal cord injury patients in the UK, estimates that 50,000 people will be living with a spinal cord injury in the UK by 2021. As a result, the demand for cough assist devices is expected to rise in the spinal cord injury population. Upsurge in the admission of patients suffering from diseases
According to New South Wales government data for 2020, the total number of hospitalizations among people with a history of serious spinal cord injury increased from 2,217 in 2008-09 to 3,888 in 2017-18 in New South Wales. As a result of these factors, there will be an increase in the admission of patients suffering from diseases in which the muscles of the body weaken, making coughing difficult, resulting in increased product demand from hospitals. Opportunities
- Rising prevalence of respiratory problems
The rising prevalence of respiratory problems is the primary driver of the cough assist device market. Furthermore, changing lifestyle factors such as smoking and high air pollution have all contributed to the use of this portable cough assist device. The individual does not have to pay for a hospital bed or medication every time he has an airway disorder. The cough assist device allows the patient easy access to the device. According to the Reinsurance Group of America, 90% of the four million people who die each year from chronic respiratory diseases are from low- and middle-income countries. While respiratory system infections and tuberculosis are prevalent in developing countries, chronic obstructive pulmonary disease, asthma, and lung cancer are prevalent in developed countries. This factor is expected to drive demand for cough assist devices.
Restraints/Challenges
- Lack of awareness
The easy availability of alternative options, as well as a lack of awareness in developing economies about the benefits of the devices, are acting as market restraints for the growth of cough assist devices during the forecast period.
This cough assist devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cough assist devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, Hillrom will introduce two new respiratory therapy devices the VolaraTM System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the SynclaraTM Cough System.
- In 2020, ABM Respiratory Care received FDA clearance for BiWaze Cough, a device for clearing bronchopulmonary secretions.
Global Cough Assist Devices Market Scope
The cough assist devices market is segmented on the basis of product, choice of delivery, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Automatic Cough Assist Device
- Manual Cough Assist Device
Choice of Delivery
- Face Mask
- Mouth Piece
- Adapter
End User
- Hospitals
- Home Care Settings
- Other End Users
Cough Assist Devices Market Regional Analysis/Insights
The cough assist devices market is analyzed and market size insights and trends are provided by country, product, choice of delivery, and end user as referenced above.
The countries covered in the cough assist devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cough assist devices market due to the growing occurrences of respiratory disorders, rising awareness among the people, and prevalence of various market players in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the prevalence of geriatric population and number of smokers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The cough assist devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cough assist devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cough assist devices market. The data is available for historic period 2011-2021.Competitive Landscape and Cough Assist Devices Market Share Analysis
The cough assist devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cough assist devices market.
Some of the major players operating in the cough assist devices market are:
- Koninklijke Philips N.V. (Netherlands)
- Hill-Rom Holdings, Inc. (U.S.)
- Percussionaire Corp. (U.S.)
- Ventec Life Systems (U.S.)
- Air Liquide Medical Systems (India)
- Viemed (U.S.)
- West Care Medical (Canada)
- McKesson Medical-Surgical (U.S.)
- Aetna Inc. (U.S.)
- Dymedso (U.S.)
- PARI GmbH (Germany)
- Monaghan (U.S.)
SKU-